Filing Details
- Accession Number:
- 0001615774-18-003217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-02 17:38:45
- Reporting Period:
- 2018-03-22
- Accepted Time:
- 2018-05-02 17:38:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1621443 | Zynerba Pharmaceuticals Inc. | ZYNE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405685 | Michael Rapp | 9701 Collins Avenue, #1902-S Bal Harbor FL 33154 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-02 | 15,000 | $10.46 | 1,494,115 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.50, inclusive. The reporting person undertakes to provide to Zynerba, any security holder of Zynerba, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.